Editor
After 100 years of relatively quiet existence as a maker of diabetes drugs, the Danish firm Novo Nordisk has suddenly grown so big that the company is reshaping the Danish economy.
The reason: Ozempic and Wegovy, two drugs made by Novo Nordisk that have been proclaimed as revolutionary in the field of obesity.
The company’s booming success now explains almost all of Denmark’s recent economic growth, and the surge in overseas sales in the…
